Consecutive Dual-Session tDCS in Chronic Subjective Severe to Catastrophic Tinnitus With Normal Hearing

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Tinnitus, Subjective
Interventions
DEVICE

Transcranial direct current stimulation

The device used for tDCS in this study was DC-Stimulator Plus (NeuroConn GmbH, Ilmenau, Germany). The localization of stimulation area (DLPFC) was determined according to the 10/20 EEG system. Non-conducting, elastic head strap was placed around the head to prevent displacement during stimulation. The recording electrode covered with 5 x 7 cm sized traditional rectangular sponge was soaked with 6-7 mL of 0.9% NaCl saline solution per side and placed on the F3 (anode, left frontal) and F4 (cathode, right frontal) EEG location. Subjects were given 2 mA stimulation intensity for 20 min per session including fade-in and fade-out times for 20 seconds each. Interval between each session was 20 min. Sham procedure has been adopted a Fade In of current, Short Stimulation, Fade Out (FISSFO) protocol that consist of initial ramp up for 20 seconds, 2 mA stimulation for 40 seconds, and 20 seconds for ramp down. To check to impendence, brief current of 110 µA over 15ms every 550ms was delivered.

Trial Locations (1)

445-170

Dongtan Sacred Heart Hospital, Hwaseong-si

All Listed Sponsors
lead

Dongtan Sacred Heart Hospital

OTHER

NCT06423742 - Consecutive Dual-Session tDCS in Chronic Subjective Severe to Catastrophic Tinnitus With Normal Hearing | Biotech Hunter | Biotech Hunter